2023. Assessment of clinical utility and predictive potential of pre-chemotherapy soluble urokinase plasminogen activator receptor: Observational single center study. Biomolecules and Biomedicine. 23, 2 (Mar. 2023), 287–297. DOI:https://doi.org/10.17305/bjbms.2022.7857.